Amneal Pharmaceuticals Inc <AMRX.O>: UBS raises target price to $25 from $23
AMRX•Related News
MSCI completes acquisition of climate risk analytics provider First Street
MSCI•
Nasdaq trade halt <INHD.O> volatility trading pause at 09:51 AM
INHD•
Nasdaq trade halt continues <QMMM.O> reason not available at 10:23 AM
QMMM•
UBS fined $125 million by US regulators for money laundering violations
UBS•
WTW survey finds US employers struggle to measure defined contribution plan retirement readiness
WTW•